Discovery of Novel Indazole Derivatives as Orally Available β<sub>3</sub>-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side Effects.

Publication

Citation
Wada Y, Nakano S, Morimoto A, Kasahara KI, Hayashi T, Takada Y, Suzuki H, Niwa-Sakai M, Ohashi S, Mori M, Hirokawa T, Shuto S.: Discovery of Novel Indazole Derivatives as Orally Available β<sub>3</sub>-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side Effects. J Med Chem, Volume 60 (8), 2017
Authors
Hayashi T, Hirokawa T, Kasahara KI, Mori M, Morimoto A, Nakano S, Niwa-Sakai M, Ohashi S, Shuto S., Suzuki H, Takada Y, Wada Y
Journal
J Med Chem
Year
2017
PubMed
28355078
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc